This observational cohort study involved women with abnormal cytologic findings and/or positive HC2 tests, with the aim of determining the differences in the prevalence of HR HPV and HPV16/18, and the incidence of HPV-associated cervical lesions between the pre-vaccine and vaccine eras.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.